Business Context and Reporting Period
Company: Camden National Corporation (CAC)
Filing Type: Form 8-K (Current Report)
Date of Report: January 7, 2026
Event Date: January 8, 2026 (Announcement of Board Authorization)
Key Financial Metrics
This filing does not report specific revenue, profit, cash flow, margin, debt, or liquidity figures. The document focuses exclusively on a corporate action regarding share repurchases.
Material Changes and Corporate Actions
- Share Repurchase Authorization: The Board of Directors authorized a new program to repurchase up to 850,000 shares of common stock.
- Program Scope: The authorized amount represents approximately 5.0% of the Company's issued and outstanding shares as of December 31, 2025.
- Effective Date: The program became effective on January 7, 2026.
- Execution Method: Purchases may be made via open market, accelerated share repurchase transactions, or privately negotiated transactions (including Rule 10b5-1 programs).
Guidance, Outlook, and Management Commentary
Management Commentary: The timing and exact amount of repurchases will depend on market conditions, the Company's capital position, and internal capital generation. The program does not include specific price targets and may be suspended at any time.
Risks and Contingencies: The filing notes the discretionary nature of the program, with no guarantee of specific execution volume or timing.
Investor Verification Checklist
- Verify the total number of shares outstanding as of December 31, 2025, to confirm the 5.0% calculation.
- Monitor future filings for actual repurchase activity and pricing under the new program.
- Review the Company's most recent 10-K or 10-Q to assess current capital position and liquidity available for repurchases.
- Check for any concurrent announcements regarding dividend changes or other capital allocation strategies.